White Coat ceremony launches students’ careers in medicine

Weill Cornell Medical College's Class of 2021 as received their short white coats during the institution's annual White Coat Ceremony Aug. 15. officially marking the beginning of their medical education.

Mechanisms found to explain atypical femoral fractures

A research team led by Eve Donnelly, assistant professor in materials science and engineering, has published a study regarding a dangerous side effect of long-term use of bisphosphonates to treat osteoporosis.

Protein prevents excess fluid from entering lung tissue

A protein found in the cells lining blood vessels plays a central role in preventing fluid and inflammatory cells from leaking into lung tissue, Weill Cornell Medicine researchers discovered.

‘Fusion genes’ drive formation and growth of colorectal cancer

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Weill Cornell Medicine investigators.

Missing link identified between immune cells and Alzheimer’s

By studying the effects of immune cells that surround blood vessels in the brain, Weill Cornell Medicine researchers have discovered a new pathway that may contribute to Alzheimer’s disease.

Brain's network may provide insights into neurological disorders

A deeper understanding of the brain’s connectivity network of neurons and its relationship to the organ’s deep tissue could allow recognition of what processes relate to neurological disorders.

New device could make closing surgical incisions a cinch

A material strong enough to protect the intestines from a needle puncture and bendable enough to insert through a laparotomy incision that quickly dissolves in the body is being studied.

Enzyme key to triggering anti-cancer immune response

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study.

Human tissue model developed to test colon cancer drugs

The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.